Mitsubishi UFJ Asset Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.8M Buy
212,427
+7,685
+4% +$192K ﹤0.01% 680
2026
Q1
$5.12M Buy
204,742
+30,003
+17% +$845K ﹤0.01% 661
2025
Q4
$5.37M Buy
174,739
+71,832
+70% +$2.38M ﹤0.01% 659
2025
Q3
$3.67M Sell
102,907
-56,967
-36% -$2.6M ﹤0.01% 688
2025
Q2
$9.21M Buy
159,874
+83,498
+109% +$4.72M 0.01% 594
2025
Q1
$4.45M Buy
76,376
+39,516
+107% +$2.7M ﹤0.01% 659
2024
Q4
$3.11M Buy
36,860
+27,475
+293% +$2.35M ﹤0.01% 699
2024
Q3
$752K Buy
9,385
+177
+2% +$12.6K ﹤0.01% 825
2024
Q2
$563K Sell
9,208
-6,470
-41% -$385K ﹤0.01% 839
2024
Q1
$775K Sell
15,678
-735
-4% -$35K ﹤0.01% 825
2023
Q4
$663K Sell
16,413
-1,686
-9% -$57.4K ﹤0.01% 857
2023
Q3
$594K Sell
18,099
-154
-0.8% -$5.25K ﹤0.01% 874
2023
Q2
$645K Buy
18,253
+5,040
+38% +$167K ﹤0.01% 875
2023
Q1
$375K Hold
13,213
﹤0.01% 959
2022
Q4
$523K Sell
13,213
-2,434
-16% -$105K ﹤0.01% 901
2022
Q3
$649K Hold
15,647
﹤0.01% 849
2022
Q2
$512K Buy
+15,647
New +$569K ﹤0.01% 907

Other funds holding PRCT

Mitsubishi UFJ Asset Management's PRCT Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management increased its Procept Biorobotics (PRCT) stake by 3.8% in Q2 2026, buying an estimated $192K and bringing the position to 212,427 shares worth $4.8M. The position accounts for ﹤0.01% of the portfolio, ranked #680.

Mitsubishi UFJ Asset Management first reported a position in PRCT in Q2 2022 and has held it in 17 quarters since. The position peaked at $9.21M in Q2 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 212,427 shares of Procept Biorobotics worth $4.8M as of Q2 2026.
  • Mitsubishi UFJ Asset Management bought 7,685 Procept Biorobotics shares in Q2 2026, an estimated $192K.
  • Procept Biorobotics made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #680 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Procept Biorobotics in Q2 2022 and has held it in 17 quarters since.
  • Mitsubishi UFJ Asset Management's Procept Biorobotics position peaked at $9.21M in Q2 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.